These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19387115)

  • 1. Growth factors, AGEing, and the diabetes link in Alzheimer's disease.
    Loy CT; Twigg SM
    J Alzheimers Dis; 2009; 16(4):823-31. PubMed ID: 19387115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The model Caenorhabditis elegans in diabetes mellitus and Alzheimer's disease.
    Morcos M; Hutter H
    J Alzheimers Dis; 2009; 16(4):897-908. PubMed ID: 19387121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?
    Kroner Z
    Altern Med Rev; 2009 Dec; 14(4):373-9. PubMed ID: 20030463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease.
    Yamagishi S; Nakamura K; Inoue H; Kikuchi S; Takeuchi M
    Med Hypotheses; 2005; 64(6):1205-7. PubMed ID: 15823718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of toxic AGEs (TAGE) in the pathogenesis of diabetic vascular complications and Alzheimer's disease.
    Takeuchi M; Yamagishi S
    J Alzheimers Dis; 2009; 16(4):845-58. PubMed ID: 19387117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N epsilon-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease.
    Gironès X; Guimerà A; Cruz-Sánchez CZ; Ortega A; Sasaki N; Makita Z; Lafuente JV; Kalaria R; Cruz-Sánchez FF
    Free Radic Biol Med; 2004 May; 36(10):1241-7. PubMed ID: 15110389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus.
    Valente T; Gella A; Fernàndez-Busquets X; Unzeta M; Durany N
    Neurobiol Dis; 2010 Jan; 37(1):67-76. PubMed ID: 19778613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.
    Yonekura H; Yamamoto Y; Sakurai S; Petrova RG; Abedin MJ; Li H; Yasui K; Takeuchi M; Makita Z; Takasawa S; Okamoto H; Watanabe T; Yamamoto H
    Biochem J; 2003 Mar; 370(Pt 3):1097-109. PubMed ID: 12495433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-link breakers as a new therapeutic approach to cardiovascular disease.
    Susic D
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):853-6. PubMed ID: 17956231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic links between diabetes and Alzheimer's disease.
    Maher PA; Schubert DR
    Expert Rev Neurother; 2009 May; 9(5):617-30. PubMed ID: 19402773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of AST-120 (Kremezin) is a promising therapeutic strategy for advanced glycation end product (AGE)-related disorders.
    Yamagishi S; Nakamura K; Matsui T; Inoue H; Takeuchi M
    Med Hypotheses; 2007; 69(3):666-8. PubMed ID: 17331665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular factors in diabetes and Alzheimer's disease.
    Taguchi A
    J Alzheimers Dis; 2009; 16(4):859-64. PubMed ID: 19387118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A reply to Dr. Bidzan's article "Relationship between the normal aging ad Alzheimer's dementia. Practical implications].
    Krzymiński S
    Psychiatr Pol; 1994; 28(2):221-30. PubMed ID: 8208866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
    Roy S; Rauk A
    Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycation and endothelial functions: a link towards vascular complications in diabetes.
    Rojas A; Morales MA
    Life Sci; 2004 Dec; 76(7):715-30. PubMed ID: 15581904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. epsilon-Glycation, APP and Abeta in ageing and Alzheimer disease: a hypothesis.
    Schmitt HP
    Med Hypotheses; 2006; 66(5):898-906. PubMed ID: 16442744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor for advanced glycation end products and the cardiovascular complications of diabetes and beyond: lessons from AGEing.
    Yan SF; Yan SD; Herold K; Ramsamy R; Schmidt AM
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):511-24, viii. PubMed ID: 16959583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potentials of unicellular green alga Chlorella in advanced glycation end product (AGE)-related disorders.
    Yamagishi S; Nakamura K; Inoue H
    Med Hypotheses; 2005; 65(5):953-5. PubMed ID: 15996828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility of serum or cerebrospinal fluid levels of toxic advanced glycation end-products (TAGE) in early detection of Alzheimer's disease.
    Takeuchi M; Sato T; Takino J; Kobayashi Y; Furuno S; Kikuchi S; Yamagishi S
    Med Hypotheses; 2007; 69(6):1358-66. PubMed ID: 17888585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-enzymatic glycation of proteins: a cause for complications in diabetes.
    Nawale RB; Mourya VK; Bhise SB
    Indian J Biochem Biophys; 2006 Dec; 43(6):337-44. PubMed ID: 17285797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.